Key facts
- This page summarizes Claes Robert Wahlestedt's Form 3 filing for JUPITER NEUROSCIENCES, INC. (JUNS).
- 0 reported transactions and 7 derivative rows are listed below.
- Accepted by SEC: 13 Nov 2024, 20:56.
Claes Robert Wahlestedt - 08 Nov 2024 Form 3 Insider Report for JUPITER NEUROSCIENCES, INC. (JUNS)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- JUNS
- Reported as of
- 08 Nov 2024
- Net transaction value
- $0
- Reporting owner signature
- /s/ Claes Robert Wahlestedt
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Claes Robert Wahlestedt filed Form 3 for JUPITER NEUROSCIENCES, INC. (JUNS) on 13 Nov 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
JUNS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,757,353
- Date
- 08 Nov 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
JUNS
holding
Derivative
Stock option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 08 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 225,000
- Exercise price
- $0.0100
- Footnotes
- F1
JUNS
holding
Derivative
Stock option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 08 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 84,938
- Exercise price
- $0.7400
- Footnotes
- F2
JUNS
holding
Derivative
Stock option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 08 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 135,000
- Exercise price
- $0.8800
- Footnotes
- F3
JUNS
holding
Derivative
Stock option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 08 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 61,920
- Exercise price
- $1.33
- Footnotes
- F4
JUNS
holding
Derivative
Stock option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 08 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,752
- Exercise price
- $1.33
- Footnotes
- F5
JUNS
holding
Derivative
Restricted stock award
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 08 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 46,620
- Exercise price
- $0.000000
- Footnotes
- F6
JUNS
holding
Derivative
Restricted stock unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 08 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,233
- Exercise price
- $0.000000
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Fully vested stock options which were granted on January 1, 2016 under the Company's 2016 Equity Incentive Plan.
Footnote F2
Fully vested stock options which were granted on January 24, 2019 under the Company's 2016 Equity Incentive Plan.
Footnote F3
Fully vested stock options which were granted on February 1, 2020 under the Company's 2016 Equity Incentive Plan.
Footnote F4
Fully vested stock options which were granted on September 29, 2023 pursuant to the approval of the board of directors of the issuer as partial consideration for forgiveness of earned compensation owed by the issuer to the Reporting Person.
Footnote F5
Fully vested stock options which were granted on December 18, 2023 pursuant to the approval of the board of directors of the issuer as partial consideration for forgiveness of earned compensation owed by the issuer to the Reporting Person.
Footnote F6
Restricted stock awards which were granted on July 21, 2022 under the Company's 2021 Equity Incentive Plan as partial consideration for forgiveness of earned compensation owed by the issuer to the Reporting Person. The restricted stock awards vest at 100% 180 days after the first day of trading of an IPO.
Footnote F7
Restricted stock units which were granted on December 18, 2023 under the Company's 2023 Equity Incentive Plan as partial consideration for forgiveness of earned compensation owed by the issuer to the Reporting Person. The restricted stock units vest at 100% 180 days after the first day of trading of an IPO.